INNAXE

The INNAXE project in detail

INNAXE (acronym for “Inclusive & aligned INNovation Agendas across Europe”) seeks to measure the impact that different clusters' activities have on their ecosystems, with a view to better serve their stakeholders in responding to their needs.

During the first phase of the project, which will run from 2022 to 2024, the partners will agree on a set of indicators to measure the innovation performance of life sciences and health technology ecosystems and use them to compare across regions.

In the second phase, the consortium will contact regional authorities, public and private stakeholders in their regions to involve them in the project's reflection and co-creation activities.

Finally, a joint action plan will be drawn up including high-impact activities for more interconnected, inclusive, sustainable, dynamic and competitive life sciences and healthcare ecosystems in Europe.

The INNAXE project has 5 main tasks:

• To map and measure the strengths, weaknesses, capacities and needs of the partners' ecosystems.
• To assess the impact of the partners' programs and services on their ecosystems in terms of connectedness, acceleration, innovation scaling, talent and competitiveness.
• To compare practices with other clusters in a standardized way to find the most valuable practices, thus contributing to reduce fragmentation between leading and modest innovating regions.
• To strengthen the dialogue and scale up the connection between stakeholders involved in innovation at all levels of the quadruple helix, and between ecosystems, seeking to improve ecosystem-level strategies for inclusive innovation.
• To define and prepare the implementation of a long-term (5 years) joint action plan to foster the interconnectedness, inclusiveness, sustainability, dynamism and competitiveness of innovation ecosystems across the EU.

Surveys targeting clusters and key local stakeholders from industry and academia

INNAXE partners will conduct a survey targeted at clusters to receive relevant information about their organizations and the actions they carry out in order to compare cluster practices.

In addition, the partners will carry out a survey addressed to quadruple helix stakeholders to validate the actions included in the joint program.

INNAXE allows networking at the European level (CEBR) and specifically in the foreign markets of the countries and regions represented in the project:

• Île de France, France
• Rhine-Neckar, Germany
• Catalonia, Spain
• Bulgaria
• Denmark

For more information about this project and other possibilities to receive support in your company's internationalization, please contact Albert Guerrero, International Relations Department at Biocat (aguerrero@biocat.cat).

Project members

Medicen, France; BioRN, Germany; HLSC, Bulgaria; DLSC, Denmark; Council of European Bioregions and Biocat, Catalonia, who is the project’s leader.